Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 14, 2022; 28(26): 3201-3217
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3201
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3201
Table 1 The demographic and clinical data of subjects
| Group | CHB | Control | HCC |
| n | 34 | 8 | 8 |
| Age (years; 25%, 75%) | 41.00 (35.00, 48.75) | 32.50 (28.25, 41.85) | 47.00 (40.25, 53.42) |
| ALT (U/L; 25%, 75%) | 137.50 (59.00, 221.50) | 31.5000 (14.5000, 63.1725) | 48.50 (39.00, 65.25) |
| TBil (μmol/L; 25%, 75%) | 16.300 (11.500, 24.225) | 10.80 (9.42, 20.58) | 20.6 (14.5, 32.5) |
| AFP (ng/mL; 25%, 75%) | 4.5400 (2.9850, 13.1725) | 2.02 (1.05, 4.75) | 179.80 (14.65, 207.53) |
- Citation: Chen YF, Liu SY, Cheng QJ, Wang YJ, Chen S, Zhou YY, Liu X, Jiang ZG, Zhong WW, He YH. Intracellular alpha-fetoprotein mitigates hepatocyte apoptosis and necroptosis by inhibiting endoplasmic reticulum stress. World J Gastroenterol 2022; 28(26): 3201-3217
- URL: https://www.wjgnet.com/1007-9327/full/v28/i26/3201.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i26.3201